Three integrated frameworks that diagnose where EBITDA is leaking, install the operating system to fix it, and compound gains across the portfolio — delivering 2-3x faster value creation than traditional consulting or pure-play AI vendors.
Before writing a line of code or building a slide deck, we run the VFI scan, a structured diagnostic that maps every portfolio company's value gaps to dollar-denominated opportunities. The output isn't a report. It's a prioritized investment thesis for digital and AI deployment.
The VOS is how we turn diagnosis into deployed systems, fast. It's not a methodology deck. It's an execution engine: pre-built playbooks, reusable components, and a delivery cadence that puts working systems in production within 90 days, not 12 months.
Individual wins are good. Compounding wins are transformative. The CVM is the architecture for turning isolated improvements into portfolio-wide value creation, where each sprint builds on the last, each portco learns from the others, and exit multiples reflect sustained, defensible growth.
PE firms typically choose between strategy consultancies (big ideas, no execution), technology vendors (tools without strategy), and boutique AI firms (models without business context). Xivic integrates all three, and delivers on a PE timeline.
| Dimension | Strategy Consultancy | Tech Vendor | Xivic (VFI+VOS+CVM) |
|---|---|---|---|
| Starting point | Market analysis | Technology demo | EBITDA gap analysis |
| Primary deliverable | Strategy deck | Software license | Deployed, revenue-generating system |
| Time to measurable impact | 6-18 months | 12-24 months | 90 days |
| Integration depth | Recommendations only | Technology only | Strategy + Design + Tech + Growth |
| Portfolio leverage | Separate engagement per portco | Separate license per portco | Cross-pollination across portfolio |
| Exit readiness | Not addressed | Vendor dependency risk | Documented, transferable systems |
The VFI scan takes 2-3 weeks and identifies $5M-50M in addressable value per portfolio company. No commitment beyond the diagnostic.